Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

Pain management is a chronic issue that plagues the Appalachian mountains – from pharmaceutical companies rolling out ...

Cupping therapy is an ancient practice that has gained popularity in recent years, particularly among athletes and individuals seeking alternative pain management solutions. This therapy involves ...

Effective management of myofascial pain often involves various therapeutic techniques, including trigger point therapy, dry needling, and injections. Recent research has focused on evaluating the ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

"FDA approves Vertex’s acute pain treatment Journavx" was originally created and published by Pharmaceutical Technology, a ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...

Jordan Sudberg , a renowned pain management specialist, will introduce a revolutionary new shock wave treatment set to transform how patients experience pain relief and rehabilitation. This ...

Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...